Onderneming MiMedx Group Inc Nasdaq
Aandelen
US6024961012
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Hospital
58,2
%
| - | - | 187 | 58,2 % | - |
Private Office
29,8
%
| - | - | 96 | 29,8 % | - |
Other
12,0
%
| - | - | 39 | 12,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 268 | 100,0 % | 321 | 100,0 % | +20,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 27-01-23 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 05-07-23 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-21 |
Mark P. Graves
CMP | Compliance Officer | 59 | 01-07-18 |
Ricci Whitlow
COO | Chief Operating Officer | 55 | 03-01-23 |
William Hulse
ADM | Chief Administrative Officer | 50 | 02-12-19 |
David H. Mason
CTO | Chief Tech/Sci/R&D Officer | 77 | 19-06-14 |
K. Newton
BRD | Director/Board Member | 61 | 19-06-19 |
Eric Smith
SAM | Sales & Marketing | - | 01-01-21 |
Kim Moller
SAM | Sales & Marketing | - | 01-08-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 02-07-20 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 08-03-21 |
K. Newton
BRD | Director/Board Member | 61 | 19-06-19 |
M. Wilsey
CHM | Chairman | 71 | 19-06-19 |
James Bierman
BRD | Director/Board Member | 71 | 19-06-19 |
Martin Sutter
BRD | Director/Board Member | 68 | 02-07-20 |
Joe Capper
CEO | Chief Executive Officer | 60 | 27-01-23 |
Michael Giuliani
BRD | Director/Board Member | 69 | 20-11-20 |
Cato Laurencin
BRD | Director/Board Member | 65 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 147 603 955 | 144 292 915 ( 97,76 %) | 0 | 97,76 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-19,77% | 131 mln. | |
-7,43% | 67 mln. | |
+5,15% | 61,28 mln. | |
-1,80% | 51,45 mln. |